Chi Li to lead regulatory at Curevo

Vaccine company Curevo Inc. hired Chi Li as chief regulatory officer. Li was chief regulatory officer at Editas Medicine Inc. (NASDAQ:EDIT). Curevo is developing amezosvatein, a vaccine to prevent shingles. 

Zura Bio Ltd. (NASDAQ:ZURA) named Robert Lisicki as CEO and a director, succeeding founding CEO Someit Sidhu, who will remain on the company’s board. Lisicki became president and COO of Zura Bio in January. Zura is developing dual-pathway antibodies to treat autoimmune and inflammatory diseases...